IgG4rituximab:

Koji Suzuki1, Mitsuhiro Akiyama2, Hiroyuki Fukui2

  • 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. ksuzuki0418@keio.jp.

Rheumatology international
|December 31, 2024
PubMed
概括

影响冠状动脉的免疫球蛋白G4相关疾病 (IgG4-RD) 是罕见但严重的. 利图西马布有效治疗IgG4相关的冠状动脉周炎,提供了一个新的治疗选择.